Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H29NO2 |
| Molecular Weight | 291.4284 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)COC1=CC=CC=C1C2CCCCC2
InChI
InChIKey=ABXHHEZNIJUQFM-UHFFFAOYSA-N
InChI=1S/C18H29NO2/c1-14(2)19-12-16(20)13-21-18-11-7-6-10-17(18)15-8-4-3-5-9-15/h6-7,10-11,14-16,19-20H,3-5,8-9,12-13H2,1-2H3
| Molecular Formula | C18H29NO2 |
| Molecular Weight | 291.4284 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Exaprolol is a non-selective antagonist at beta-adrenoceptors exerting antiarrhythmic and local anesthetic activity. It inhibits the inotropic and chronotropic responses. Exaprolol liberates histamine from isolated mast cells and decreases the uptake of extracellular histamine. It acts on mast cells due to the direct and indirect ion exchange mechanism resulted in disproportion between histamine and granule liberation.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PET. | 2007-08-31 |
|
| PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage? | 2004 |
|
| Histamine liberation as a result of nonreceptor interaction. | 1990-04 |
|
| Aspects of the cardiovascular pharmacology of exaprolol. | 1984-09 |
|
| Evidence for intracellular histamine liberation in isolated rat mast cells. | 1982-12 |
|
| Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol. | 1976-04 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:50:10 GMT 2025
by
admin
on
Wed Apr 02 07:50:10 GMT 2025
|
| Record UNII |
Q4XX54I93R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20866509
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
SUB07491MIG
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
Q4XX54I93R
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
65485
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
C65609
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
55837-19-9
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110841
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
Exaprolol
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
100000081529
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
3706
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY | |||
|
C012969
Created by
admin on Wed Apr 02 07:50:10 GMT 2025 , Edited by admin on Wed Apr 02 07:50:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |